Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.40
+0.03 (0.47%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Lifecore Biomedical stock have an average target of $6.28, which predicts a -1.88% decrease from the current stock price of 6.4.
Price Target: $6.28 (-1.88%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 3, 2026 |
| Barrington | Barrington | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Sep 29, 2026 |
| Craig-Hallum | Craig-Hallum | Hold Downgrades $6.28 | Hold | Downgrades | $6.28 | -1.88% | Sep 28, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 6, 2026 |
Financial Forecast
Revenue This Year
121.53M
from 128.87M
Decreased by -6.13%
Revenue Next Year
130.61M
from 121.53M
Increased by 7.47%
EPS This Year
-0.88
from -0.43
EPS Next Year
-0.78
from -0.88
EPS and Forward PE are based on non-GAAP adjusted numbers.